Find uplifting stories about heroes, innovations, and solutions
7153 results for "vaccine safety"
Health and Human Services is developing an artificial intelligence tool to analyze vaccine safety data more effectively and identify potential health patterns. The technology could help researchers spot safety signals faster in a database that's been collecting reports since 1990.
A leading elevator company chairman is teaching parents simple safety habits that could prevent elevator accidents involving children. These easy-to-learn tips turn everyday elevator rides into teachable moments about safety.
After three decades without a combined measles, mumps, and rubella vaccine, Japan has cleared the way for families to protect their children with a single shot instead of multiple jabs. The decision marks a turning point in the country's immunization program, which suspended MMR vaccines in 1993 due to safety concerns.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
A groundbreaking vaccine against a bacteria that sickens millions worldwide just passed human safety trials with flying colors. The sugar-based shot could prevent a leading cause of severe diarrhea and save lives across the globe.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
A rigorous study of 434 toddlers finds no connection between mRNA COVID vaccines during pregnancy and autism or developmental delays. The research offers strong reassurance for expectant mothers making vaccine decisions.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
Ghana is launching a nationwide typhoid vaccine program targeting food handlers, shifting from reactive treatment to proactive prevention. The subsidized vaccine will be required for health certificates starting in coming weeks.
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A global research team discovered exactly why a tiny number of people developed blood clots after certain COVID-19 vaccines, and their breakthrough points the way to even safer vaccines. The answer lies in a single mutation that misdirects the immune system in extraordinarily rare cases.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
Showing 20 of 7153